IMVT·45258J102·US·equity·Healthcare - Biotechnology-Activist
IMVT (IMMUNOVANT INC) is held by 122 institutional investors as of Q1 2026. Largest holders: FMR LLC ($421M), BlackRock, Inc. ($163.3M), BAKER BROS. ADVISORS LP ($135.6M). Net institutional sentiment: Bullish.
See how IMVT's score breaks down across 4 SEC sources
Showing 1-20 of 128
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer